Gilead and Kite present blood cancer therapy data at ASH annual meeting

GILD•2026-11-04

Gilead Sciences and Kite will attend the 68th American Society of Hematology Annual Meeting and Exposition on December 12-15, 2026, with 23 presentations, including seven oral presentations.

1. ASH presentations

Gilead Sciences and Kite will attend the 68th American Society of Hematology Annual Meeting and Exposition on December 12-15, 2026. The companies' program includes 23 presentations, seven of them oral.

Gilead and Kite present blood cancer therapy data at ASH annual meeting

1. ASH presentations

Related News

Metagenomi reports preclinical proof of concept for MGX-001 in hemophilia A

Par Pacific forecasts 2026 capital spending and turnaround costs of $190 million-$220 million

Postal Realty Trust: Colliers cuts target price to $25

Flutter pauses share buybacks to focus on cutting costs and debt

Tradewinds Universal pursues energy expansion through talks with power technology license holder